Veru, Inc. (NASDAQ:VERU) Q3 2021 Earnings Conference Call August 12, 2021 8:00 AM ET Company Participants Samuel Fisch - Director, IR Michele Greco - CFO & Chief Administrative Officer Mitchell Steiner - Chairman, President & CEO Conference Call Participants Brandon Folkes - Cantor Fitzgerald & Co. Christopher Howerton - Jefferies Yi Chen - H.C. Wainwright & Co. Kumaraguru Raja - Brookline Capital Markets Alexandra Heller - Oppenheimer Operator Good morning, ladies and gentlemen, and welcome to Veru Inc. In ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) Commission File Number 1-13602 Veru Inc. (Exact Name of Registrant as Specified in its Charter) Wisconsin 39-1144397 48 NW 25 Street, Suite 102, Miami, FL 33127 (Address of Principal Executive Offices) (Zip Code) (State of Incorporation) (I.R.S. Employer Identification No.) 305-509-6897 (Registrant's Telephone Number, Including Area Code) N/A Indicate by check mark whether the registrant is a shell company (as deter ...

Veru Inc. Nasdaq:VERU | --- | --- | --- | --- | |------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------|-------|-------| | | | | | | Oncology Biopharmaceutical Company Focused on Prostate Cancer and Breast Cancer Veru Corporate Presentation Jefferies Virtual Healthcare Conference June 1 – June 4, 2021 | | | | Forward looking statements This communication contains forward-looking st ...

Veru, Inc. (NASDAQ:VERU) Q2 2021 Results Earnings Conference Call May 12, 2021 8:00 AM ET Company Participants Samuel Fisch - Director, Investor Relations Mitchell Steiner – Chairman, President and Chief Executive Officer Michele Greco - Chief Financial Officer and Chief Administrative Officer Conference Call Participants Christopher Howerton - Jefferies Brandon Folkes - Cantor Fitzgerald Leland Gershell - Oppenheimer & Co. Kumar Raja - Brookline Capital Markets Yi Chen - H.C. Wainwright Operator Operator G ...

FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-13602 Veru Inc. (Exact Name of Registrant as Specified in its Charter) Wisconsin 39-1144397 (State of Incorporation) (I.R.S. Employer Identification No.) th Street, Suite 102, Miami, FL 33127 UNITED STATES ...

Veru Inc. Nasdaq:VERU | --- | --- | --- | |--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------|-------| | | | | | | | | | Oncology Biopharmaceutical Company Focused on Prostate Cancer and Breast Cancer Veru Corporate Presentation Oppenheimer 31st Annual Healthcare Conference March 16-17, 2021 | | | Forward looking statements This communication contains forward-looking statemen ...

Call Start: 08:00 January 1, 0000 9:11 AM ET Veru, Inc. (NASDAQ:VERU) Q1 2021 Earnings Conference Call February 10, 2021 08:00 ET Company Participants Sam Fisch - Director IR Mitchell Steiner - Chairman, CEO & President Michele Greco - CFO & CAO Gary Barnette - Chief Scientific Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Yi Chen - H.C. Wainwright Kumar Raja - Brookline Capital Markets Leland Gershell - Oppenheimer Peter McMullin - Peter McMullin Consulting Operator Good morning, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-13602 Veru Inc. (Exact Name of Registrant as Specified in its Charter) Wisconsin 39-1144397 (State of Incorporation) (I.R.S. Emplo ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-13602 Veru Inc. (Name of registrant as specified in its charter) | Wisconsin | 39-1144397 | | --- | --- | | (State or other jurisdiction ...

Veru, Inc. (NASDAQ:VERU) Q4 2020 Earnings Conference Call December 9, 2020 8:00 AM ET Company Participants Sam Fisch - Director, IR Mitchell Steiner - Chairman, CEO, and President Michele Greco - CFO and CAO Conference Call Participants Brandon Folkes - Cantor Fitzgerald Yi Chen - H.C. Wainwright Leland Gershell - Oppenheimer Kumar Raja - Brookline Capital Markets Peter McMullin - Peter McMullin Consulting Operator Good morning, ladies and gentlemen, and welcome to Veru, Inc.'s Investors Conference Call. Al ...